Article Detail - JE Part B
MolDX: MGMT Promoter Methylation Analysis - R5 - Effective October 14, 2021
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Medicare Coverage Database (MCD) Number: L36188
LCD Title: MolDX: MGMT Promoter Methylation Analysis
Effective Date: October 14, 2021
Summary of Changes: Under CMS National Coverage Policy added regulation CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80.1.1 Certification Changes and updated descriptions to regulations.
Under Bibliography changes were made to citations to reflect AMA citation guidelines. Formatting, punctuation, and typographical errors were corrected throughout the LCD.
Visit the Molecular Diagnostic Services (MolDX) webpage to access the locally hosted MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.
To view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.
Last Updated Wed, 03 Nov 2021 16:07:43 +0000